A Novel Electrochemiluminescent Immunoassay based on Target Transformation Assisted with Catalyzed Hairpin Assembly Amplification for the Ultrasensitive Bioassay.

Hu-Xin Lei,Chang-Chun Niu,Tian Li,Ya-Fang Wan,Wen-Bin Liang,Ruo Yuan,Pu Liao
DOI: https://doi.org/10.1021/acsami.9b12428
IF: 9.5
2019-01-01
ACS Applied Materials & Interfaces
Abstract:In this work, we constructed a novel electrochemiluminescent (ECL) strategy based on sandwich immunoassay-induced target transformation assisted with catalyzed hairpin assembly (CHA) amplification for ultrasensitive bioassay with cysteine-rich protein 61 (CCN1) as a model. Firstly, the target CCN1 could be equally transformed to the specific oligonucleotide (Initiator I) labeled on the detection antibody (DAb) based on the specific sandwich immunoassay. And then, the Initiator I triggered an efficient non-enzymatic CHA amplification in the presence of ferrocene labeled hairpin 1 (Fc-H1) and hairpin 2 (H2) to produce massive hybrids (Fc-H1-H2) containing a sticky end labeled with ferrocene. Finally, Fc-H1-H2 could be immobilized on the capture probe (ssDNA) modified electrode through the hybridization between the sticky end of Fc-H1-H2 and ssDNA, and a significantly quenched ECL signal could be obtained due to the efficient quench effect between ferrocene and the ECL indicator, ruthenium (II) tris (4,4'-dicarboxylicacid-2,2'-bipyridyl) [Ru(dcbpy)32+], immobilized on the surface of electrode, which was related to the concentration of target CCN1. As expected, the proposed ECL biosensor performed a relatively low detection limit of 3.9 fg/mL in a linear range from 10 fg/mL to 100 ng/mL. This ECL strategy exhibited a great inspiration for clinical examination of the biomarker CCN1, providing a potential application in early diagnosis and malignant monitoring of cancer.
What problem does this paper attempt to address?